Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rosalie Nolley

Showing results (1-10 of 54) with videos related to

Pageof 6
Sort By:
The Prostate|June 29, 2010
Serum Mac-2BP does not distinguish men with high grade, large volume prostate cancer from men with benign prostatic hyperplasiaDonna M Peehl, Zuxiong Chen, Rosalie Nolley
Laboratory Investigation; a Journal of Technical Methods and Pathology|December 4, 2013
Optimization and comprehensive characterization of a faithful tissue culture model of the benign and malignant human prostateSophia Lisette Maund, Rosalie Nolley, Donna Mae Peehl
The American Journal of Pathology|May 18, 2010
Tissue slice grafts: an in vivo model of human prostate androgen signalingHongjuan Zhao, Rosalie Nolley, Zuxiong Chen, et al.
The Journal of Urology|July 11, 2003
Prognostic factors for multifocal prostate cancer in radical prostatectomy specimens: lack of significance of secondary cancersMasanori Noguchi, Thomas A Stamey, John E McNeal, et al.
Differentiation; Research in Biological Diversity|February 6, 2008
Inhibition of monoamine oxidase A promotes secretory differentiation in basal prostatic epithelial cellsHongjuan Zhao, Rosalie Nolley, Zuxiong Chen, et al.
The Journal of Urology|September 23, 2008
The significance of monoamine oxidase-A expression in high grade prostate cancerDonna M Peehl, Marc Coram, Htet Khine, et al.
Plos One|April 16, 2015
Elevated serum microRNA levels associate with absence of high-grade prostate cancer in a retrospective cohortBrittany L Mihelich, Joseph C Maranville, Rosalie Nolley, et al.
Cancer Biology & Therapy|October 8, 2016
Cabozantinib inhibits tumor growth and metastasis of a patient-derived xenograft model of papillary renal cell carcinoma with MET mutationHongjuan Zhao, Rosalie Nolley, Andy M W Chan, et al.
Endocrine-Related Cancer|June 29, 2014
Nuclear KLLN expression associates with improved relapse-free survival for prostate carcinomaYu Wang, Andres Roma, Rosalie Nolley, et al.
The Journal of Urology|September 17, 2004
The prostate specific antigen era in the United States is over for prostate cancer: what happened in the last 20 years?Thomas A Stamey, Mitchell Caldwell, John E McNeal, et al.
Pageof 6

Showing results (1-10 of 54) with videos related to

Sort By:
Pageof 6
The Prostate|June 29, 2010
Serum Mac-2BP does not distinguish men with high grade, large volume prostate cancer from men with benign prostatic hyperplasiaDonna M Peehl, Zuxiong Chen, Rosalie Nolley
Laboratory Investigation; a Journal of Technical Methods and Pathology|December 4, 2013
Optimization and comprehensive characterization of a faithful tissue culture model of the benign and malignant human prostateSophia Lisette Maund, Rosalie Nolley, Donna Mae Peehl
The American Journal of Pathology|May 18, 2010
Tissue slice grafts: an in vivo model of human prostate androgen signalingHongjuan Zhao, Rosalie Nolley, Zuxiong Chen, et al.
The Journal of Urology|July 11, 2003
Prognostic factors for multifocal prostate cancer in radical prostatectomy specimens: lack of significance of secondary cancersMasanori Noguchi, Thomas A Stamey, John E McNeal, et al.
Differentiation; Research in Biological Diversity|February 6, 2008
Inhibition of monoamine oxidase A promotes secretory differentiation in basal prostatic epithelial cellsHongjuan Zhao, Rosalie Nolley, Zuxiong Chen, et al.
The Journal of Urology|September 23, 2008
The significance of monoamine oxidase-A expression in high grade prostate cancerDonna M Peehl, Marc Coram, Htet Khine, et al.
Plos One|April 16, 2015
Elevated serum microRNA levels associate with absence of high-grade prostate cancer in a retrospective cohortBrittany L Mihelich, Joseph C Maranville, Rosalie Nolley, et al.
Cancer Biology & Therapy|October 8, 2016
Cabozantinib inhibits tumor growth and metastasis of a patient-derived xenograft model of papillary renal cell carcinoma with MET mutationHongjuan Zhao, Rosalie Nolley, Andy M W Chan, et al.
Endocrine-Related Cancer|June 29, 2014
Nuclear KLLN expression associates with improved relapse-free survival for prostate carcinomaYu Wang, Andres Roma, Rosalie Nolley, et al.
The Journal of Urology|September 17, 2004
The prostate specific antigen era in the United States is over for prostate cancer: what happened in the last 20 years?Thomas A Stamey, Mitchell Caldwell, John E McNeal, et al.
Pageof 6